EHC250516C65000
- 0.00
- 0.000.00%
Encompass Health Newsroom
Raymond James Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $120
William Blair Maintains Encompass Health(EHC.US) With Buy Rating
Encompass Health: Strong Financial Performance and Resilient Growth Justify Buy Rating
Barclays Maintains Encompass Health(EHC.US) With Buy Rating, Maintains Target Price $118
William Blair Initiates Encompass Health(EHC.US) With Buy Rating
William Blair Sticks to Its Buy Rating for Encompass Health (EHC)
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating, Announces Target Price $116
Encompass Health's Strong Q4 2024 Performance and Favorable Outlook Justifies Buy Rating
RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Maintains Target Price $110
RBC Capital Reaffirms Their Buy Rating on Encompass Health (EHC)
Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Zoetis (ZTS) and Encompass Health (EHC)
Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $120
Encompass Health Is Maintained at Overweight by Barclays
Encompass Health Analyst Ratings
Mizuho Securities Maintains Encompass Health(EHC.US) With Buy Rating
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating
Encompass Health (EHC) Receives a Buy From Truist Financial
BofA Securities Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $125
Barclays Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $118
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH), Encompass Health (EHC) and Globus Medical (GMED)